GB9901739D0 - Polypeptide - Google Patents

Polypeptide

Info

Publication number
GB9901739D0
GB9901739D0 GBGB9901739.4A GB9901739A GB9901739D0 GB 9901739 D0 GB9901739 D0 GB 9901739D0 GB 9901739 A GB9901739 A GB 9901739A GB 9901739 D0 GB9901739 D0 GB 9901739D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9901739.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Priority to GBGB9901739.4A priority Critical patent/GB9901739D0/en
Publication of GB9901739D0 publication Critical patent/GB9901739D0/en
Priority to PCT/GB1999/003859 priority patent/WO2000029428A2/en
Priority to GB0127673A priority patent/GB2370572B/en
Priority to AU13949/00A priority patent/AU766954B2/en
Priority to GB0224538A priority patent/GB2378704B/en
Priority to GB0127669A priority patent/GB2370571B/en
Priority to GB0014986A priority patent/GB2347932B/en
Priority to AT99972219T priority patent/ATE293690T1/en
Priority to EP01201447.8A priority patent/EP1152060B1/en
Priority to EP01201448A priority patent/EP1160323A1/en
Priority to EP09000205A priority patent/EP2042598A1/en
Priority to KR1020017006155A priority patent/KR20010084935A/en
Priority to JP2000582415A priority patent/JP4907767B2/en
Priority to CA002351622A priority patent/CA2351622A1/en
Priority to CNB998156329A priority patent/CN1298851C/en
Priority to GB0127675A priority patent/GB2370573A/en
Priority to CN 200610168977 priority patent/CN101134102B/en
Priority to EP99972219A priority patent/EP1036091B2/en
Priority to DE69924826T priority patent/DE69924826T8/en
Priority to US09/533,798 priority patent/US7148035B1/en
Priority to US10/774,176 priority patent/US20040265275A1/en
Priority to US11/286,056 priority patent/US7601698B2/en
Priority to US11/456,530 priority patent/US20090191230A1/en
Priority to US11/532,816 priority patent/US7666669B2/en
Priority to US11/686,793 priority patent/US7615612B2/en
Priority to US12/637,350 priority patent/US20100233126A1/en
Pending legal-status Critical Current

Links

GBGB9901739.4A 1998-11-18 1999-01-27 Polypeptide Pending GB9901739D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GBGB9901739.4A GB9901739D0 (en) 1999-01-27 1999-01-27 Polypeptide
DE69924826T DE69924826T8 (en) 1998-11-18 1999-11-18 USE OF CANCER ASSOCIATED ANTIGEN 5T4 TO IMMUNE THERAPY
JP2000582415A JP4907767B2 (en) 1998-11-18 1999-11-18 Polypeptide
CNB998156329A CN1298851C (en) 1998-11-18 1999-11-18 Polypeptide
AU13949/00A AU766954B2 (en) 1998-11-18 1999-11-18 Polypeptide
GB0224538A GB2378704B (en) 1998-11-18 1999-11-18 Uses of 5t4 antigen
GB0127669A GB2370571B (en) 1998-11-18 1999-11-18 A modified 5t4 antigen
GB0014986A GB2347932B (en) 1998-11-18 1999-11-18 Vectors for the delivery of 5T4 antigen
AT99972219T ATE293690T1 (en) 1998-11-18 1999-11-18 USE OF CANCER-ASSOCIATED ANTIGEN 5T4 FOR IMMUNOTHERAPY
EP01201447.8A EP1152060B1 (en) 1998-11-18 1999-11-18 5T4 tumour-associated antigen for use in tumour immunotherapy
EP01201448A EP1160323A1 (en) 1998-11-18 1999-11-18 5T4 tumour-associated antigen for use in tumour immunotherapy
EP09000205A EP2042598A1 (en) 1998-11-18 1999-11-18 5T4 tumour-associated antigen for use in tumour immunotherapy
KR1020017006155A KR20010084935A (en) 1998-11-18 1999-11-18 Polypeptide
PCT/GB1999/003859 WO2000029428A2 (en) 1998-11-18 1999-11-18 5t4 tumour-associated antigen for use in tumour immunotherapy
CA002351622A CA2351622A1 (en) 1998-11-18 1999-11-18 Polypeptide
GB0127673A GB2370572B (en) 1998-11-18 1999-11-18 Use of a professional antigen presenting cell
GB0127675A GB2370573A (en) 1998-11-18 1999-11-18 Poxviral vectors
CN 200610168977 CN101134102B (en) 1998-11-18 1999-11-18 5T4 antigen-expressed vector
EP99972219A EP1036091B2 (en) 1998-11-18 1999-11-18 5t4 tumour-associated antigen for use in tumour immunotherapy
US09/533,798 US7148035B1 (en) 1998-11-18 2000-03-24 Polypeptide
US10/774,176 US20040265275A1 (en) 1998-11-18 2004-02-06 Polypeptide
US11/286,056 US7601698B2 (en) 1998-11-18 2005-11-22 Polypeptide
US11/456,530 US20090191230A1 (en) 1998-11-18 2006-07-10 Cascade
US11/532,816 US7666669B2 (en) 1998-11-18 2006-09-18 Polypeptide
US11/686,793 US7615612B2 (en) 1998-11-18 2007-03-15 Polypeptide
US12/637,350 US20100233126A1 (en) 1998-11-18 2009-12-14 Polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9901739.4A GB9901739D0 (en) 1999-01-27 1999-01-27 Polypeptide

Publications (1)

Publication Number Publication Date
GB9901739D0 true GB9901739D0 (en) 1999-03-17

Family

ID=10846550

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9901739.4A Pending GB9901739D0 (en) 1998-11-18 1999-01-27 Polypeptide

Country Status (1)

Country Link
GB (1) GB9901739D0 (en)

Similar Documents

Publication Publication Date Title
GB0128994D0 (en) Peptides
GB9923177D0 (en) Novel polypeptide
GB9921125D0 (en) Proteins
EP1197556A4 (en) Useful polypeptide
GB9923889D0 (en) Novel polypeptide
EP1147130A4 (en) Alpha-conotoxin peptides
EP1162269A4 (en) Novel polypeptide
GB9904695D0 (en) Peptide
EP1159288A4 (en) Alpha-conotoxin peptides
GB9924951D0 (en) Novel polypeptide
EP1179540A4 (en) Novel polypeptide
GB9908920D0 (en) Peptide
GB9903408D0 (en) Peptides
HK1045173A1 (en) Polypeptide
GB9923890D0 (en) Novel polypeptide
GB9923893D0 (en) Novel polypeptide
GB9920000D0 (en) Polypeptides
GB9923888D0 (en) Novel polypeptide
GB9925115D0 (en) Novel polypeptide
GB9924960D0 (en) Novel polypeptide
GB9918680D0 (en) Polypeptide
EP1151100A4 (en) Tau-conotoxin peptides
GB9924956D0 (en) Novel polypeptide
IL149355A0 (en) Polypeptide corporation
GB9901739D0 (en) Polypeptide